Expert Opinion on Biological Therapy, 18 (SUP1), 193
J Internal Med
Together, they address both vascular supply and cellular repair simultaneously, potentially accelerating overall tissue regeneration timelines beyond what either peptide achieves alone in preclinical models
Without the preservative, every needle puncture introduces bacteria into the vial with no defense
This blog explores three regenerative therapies currently used in clinical practice for EDS, stem cell therapy, platelet-rich plasma (PRP), and prolotherapy, and presents evidence of their benefits for EDS subtypes where they are most applicable
The numbers that circulate come from compounding-clinic practice and preclinical work, and theyre general protocol guidance rather than a recommendation